Difflam (n = 25) | Placebo (n = 18) | Difference (%) | p Value | |
---|---|---|---|---|
Entire study (6 weeks) | ||||
Number of episodes | 14 | 14 | – | – |
Proportion of group reporting (%) | 52 | 56 | 8 | 0.82 |
Mean duration (days) | 3.9 (4.9) | 4.1 (3.7) | 5.6 | 0.84 |
Mean episode severity score (AU) | 4.7 (7.3) | 5.2 (7.3) | 9.3 | 0.78 |
Treatment period (3 weeks) | ||||
Number of episodes | 8 | 10 | – | – |
Proportion of group reporting (%) | 32 | 50 | 56 | 0.23 |
Mean duration (days) | 3.8 (5.6) | 5.0 (4.6) | 23.7 | 0.49 |
Mean episode severity score (AU) | 4.7 (7.4) | 6.6 (9.6) | 28.9 | 0.45 |
Data are presented as mean (SD) where appropriate. The episode severity score is reported in arbitrary units.